# | Title | Journal | Year | Citations |
---|
1 | Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update | Fundamental and Clinical Pharmacology | 2005 | 920 |
2 | The Hill equation: a review of its capabilities in pharmacological modelling | Fundamental and Clinical Pharmacology | 2008 | 645 |
3 | Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review | Fundamental and Clinical Pharmacology | 2006 | 352 |
4 | Animal models of neuropathic pain | Fundamental and Clinical Pharmacology | 2011 | 283 |
5 | The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning | Fundamental and Clinical Pharmacology | 2005 | 269 |
6 | Research review on the pharmacological effects of astragaloside IV | Fundamental and Clinical Pharmacology | 2017 | 258 |
7 | Drug‐induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies | Fundamental and Clinical Pharmacology | 2008 | 251 |
8 | Tissue injury by reactive oxygen species and the protective effects of flavonoids | Fundamental and Clinical Pharmacology | 1998 | 250 |
9 | Modulation of neurotransmitter release via histamine H3 heteroreceptors | Fundamental and Clinical Pharmacology | 1994 | 246 |
10 | Dopamine, depression and antidepressants | Fundamental and Clinical Pharmacology | 2004 | 244 |
11 | Clinical pharmacology in the geriatric patient | Fundamental and Clinical Pharmacology | 2007 | 242 |
12 | Gastrointestinal absorption of drugs: methods and studies | Fundamental and Clinical Pharmacology | 1999 | 233 |
13 | Gender and the renin–angiotensin–aldosterone system | Fundamental and Clinical Pharmacology | 2010 | 217 |
14 | Animal models of anxiety in mice | Fundamental and Clinical Pharmacology | 2007 | 203 |
15 | Herb-drug interactions: an overview of the clinical evidence | Fundamental and Clinical Pharmacology | 2005 | 197 |
16 | The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery | Fundamental and Clinical Pharmacology | 2008 | 197 |
17 | Ginkgo biloba extracts and cancer: a research area in its infancy | Fundamental and Clinical Pharmacology | 2003 | 194 |
18 | Role of 5‐HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies | Fundamental and Clinical Pharmacology | 1996 | 190 |
19 | Distinct isoforms (COX‐1 and COX‐2) of cyclooxygenase: possible physiological and therapeutic implications | Fundamental and Clinical Pharmacology | 1996 | 187 |
20 | Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life | Fundamental and Clinical Pharmacology | 2004 | 170 |
21 | Drugs and their molecular targets: an updated overview | Fundamental and Clinical Pharmacology | 2008 | 170 |
22 | The efficacy of herbal medicine - an overview | Fundamental and Clinical Pharmacology | 2005 | 168 |
23 | Pharmacogenetics of the major polymorphic metabolizing enzymes | Fundamental and Clinical Pharmacology | 2003 | 167 |
24 | Long-term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans | Fundamental and Clinical Pharmacology | 2005 | 167 |
25 | Phytol, a diterpene alcohol, inhibits the inflammatory response by reducing cytokine production and oxidative stress | Fundamental and Clinical Pharmacology | 2014 | 161 |
26 | Drug metabolism and disposition in children | Fundamental and Clinical Pharmacology | 2003 | 160 |
27 | Invited review: the evolution of antidepressant mechanisms | Fundamental and Clinical Pharmacology | 2004 | 158 |
28 | Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension | Fundamental and Clinical Pharmacology | 2008 | 153 |
29 | Metabolic drug interactions with new psychotropic agents | Fundamental and Clinical Pharmacology | 2003 | 152 |
30 | Analysis of drug transporter expression in human intestinal Caco‐2 cells by real‐time PCR | Fundamental and Clinical Pharmacology | 2007 | 149 |
31 | The therapeutic potential of NO-NSAIDs | Fundamental and Clinical Pharmacology | 2003 | 147 |
32 | Emerging trends of nanomedicine – an overview | Fundamental and Clinical Pharmacology | 2009 | 143 |
33 | Hepatoprotective activity of picroliv, curcumin and ellagic acid compared to silymarin on paracetamol induced liver toxicity in mice | Fundamental and Clinical Pharmacology | 2009 | 142 |
34 | Serotonin syndrome: history and risk | Fundamental and Clinical Pharmacology | 1998 | 141 |
35 | PREVENTION OF CCL4‐INDUCED LIVER CIRRHOSIS BY SILYMARIN | Fundamental and Clinical Pharmacology | 1989 | 140 |
36 | Pharmacoepidemiology of anabolic androgenic steroids: a review | Fundamental and Clinical Pharmacology | 2005 | 139 |
37 | Gastrointestinal effects of nonsteroidal anti-inflammatory drugs | Fundamental and Clinical Pharmacology | 2003 | 135 |
38 | Opioid and anti‐opioid peptides | Fundamental and Clinical Pharmacology | 1995 | 131 |
39 | Treatment perspectives for human African trypanosomiasis | Fundamental and Clinical Pharmacology | 2003 | 128 |
40 | Current and future therapy in Alzheimer’s disease | Fundamental and Clinical Pharmacology | 2008 | 128 |
41 | Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies | Fundamental and Clinical Pharmacology | 2000 | 124 |
42 | Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans | Fundamental and Clinical Pharmacology | 2004 | 124 |
43 | Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test | Fundamental and Clinical Pharmacology | 2003 | 122 |
44 | Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes | Fundamental and Clinical Pharmacology | 2004 | 120 |
45 | Mechanisms of hypokalemia‐induced ventricular arrhythmogenicity | Fundamental and Clinical Pharmacology | 2010 | 119 |
46 | Potassium channel openers: pharmacological and clinical aspects | Fundamental and Clinical Pharmacology | 1992 | 117 |
47 | The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum | Fundamental and Clinical Pharmacology | 2003 | 117 |
48 | Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo | Fundamental and Clinical Pharmacology | 2013 | 116 |
49 | A randomized, double‐blind, multicentre controlled trial of ibuprofen versus acetaminophen and placebo for symptoms of acute otitis media in children | Fundamental and Clinical Pharmacology | 1996 | 115 |
50 | Dopamine agonists in Parkinson's disease: a look at apomorphine | Fundamental and Clinical Pharmacology | 1993 | 113 |